Overview Company Profile Presentation Company Presentation Reports Immediate Reports Financial Financial Reports Investors News Financial Reports Management Management Stock Stock Chart FAQ FAQ Alert Mail Alert Contact Contact IR Stock Quote Tel Aviv: MRHL 32.50 Price -1.52% Change percentage -0.50 Change Day High 34.30 Day Low: 31.70 Last Update: 08-02-2023 16:18 Presentations Investors Presentation - June 2021 (E) Investors Presentation - virtual investor conference to be held on 24.2.21 Investors Presentation - May 2020 - Hebrew Financial Reports 2nd Quarter 2022 4th Quarter & Full year 2021 Immediate Reports Obtaining FDA approval for the Cardiacense medical wristwatch (5.12%) 08/01/2023 CD’X (about 5.5%) in a distribution agreement with a testing laboratory in the USA for the detection of prostate cancer using IsoPSA 25/12/2022 Results of General Meeting held on Nov 8, 2022 08/11/2022 CD’X (about 5.5%) received approval from an American health insurer to cover the use of IsoPSA for the early diagnosis of prostate cancer 11/10/2022 Read more Investors News CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation 10/02/2021 Globes: 32 million distribution agreement for Cardiacsens from Merchavia Group 08/06/2020 Buinees Today: Israel’s CardiacSense signs $32.4 million deal to sell medical watches in India 08/06/2020 Yahoo Finance: Israeli tech firm to sell $32.4 million in medical watches in India 07/06/2020 Read more News in the Media OCON’s Pioneering IUB™ Ballerine® Femtech Applauded by Frost & Sullivan 23/04/2021 MERCHAVIA Holding and Investments Announces the nomination of Dr. Eran Schenker as Medical Director 04/01/2021 Innovative Israeli Medical Devices in the UAE: The Cardiacsense Medical Watch for Identifying Arrythmia Will be Sold in the UAE 15/09/2020 A Significant Vote of Confidence in Merchavia Holdings and Investments Ltd: More Investment House will lead a 4 million-shekel round of investment 14/09/2020 Read more Mail Alert Subscribe to Receive Notifications by Email: First Name Last Name Email Send Stock Price Tel Aviv: [symbol stock='257014'] [last_known_rate stock='257014'] Price [base_rate_change_percentage stock='257014'] Change percentage [base_rate_change stock='257014'] Change [daily_highest_rate stock='257014'] [daily_lowest_rate stock='257014'] Last Update:[last_Known_Rate_date stock='257014'] at:[last_Known_Rate_time stock='257014']
CD’X (about 5.5%) in a distribution agreement with a testing laboratory in the USA for the detection of prostate cancer using IsoPSA 25/12/2022
CD’X (about 5.5%) received approval from an American health insurer to cover the use of IsoPSA for the early diagnosis of prostate cancer 11/10/2022
CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation 10/02/2021
Buinees Today: Israel’s CardiacSense signs $32.4 million deal to sell medical watches in India 08/06/2020
MERCHAVIA Holding and Investments Announces the nomination of Dr. Eran Schenker as Medical Director 04/01/2021
Innovative Israeli Medical Devices in the UAE: The Cardiacsense Medical Watch for Identifying Arrythmia Will be Sold in the UAE 15/09/2020
A Significant Vote of Confidence in Merchavia Holdings and Investments Ltd: More Investment House will lead a 4 million-shekel round of investment 14/09/2020